Publications
Stay updated with Dei BioPharma’s latest breakthroughs, milestones, and industry insights in pharmaceutical innovation.
GLP-1 Receptor Agonists: Chemical Evolution and Expanding Clinical Applications
Matthias Magoola DEI Biopharma, Kampala, Uganda; dei@deigroupinternational.com Abstract: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed modern medicine, progressing from diabetes treatments to...
MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products—A Prospective Analysis
PUBLICATION BY DR. MATTHIAS MAGOOLA, CHEMIST Abstract: MicroRNAs (miRNAs) maintain cellular homeostasis by blocking mRNAs by binding with them to fine-tune...
Innovative Therapeutic Strategies in Alzheimer’s Disease: A Synergistic Approach to Neurodegenerative Disorders
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Abstract: Alzheimer’s disease (AD) remains a significant challenge in the field of neurodegenerative disorders, even nearly...
Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Abstract: Antibodies that can selectively remove rogue proteins in the brain are an obvious choice to...
Unlocking the Future of Drug Development: Generative AI, Digital Twins, and Beyond
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Abstract: This article delves into the intersection of generative AI and digital twins within drug discovery,...
Synergistic Approaches in Neurodegenerative Therapeutics: 2 Multi-Target Drug Innovative Interventions for Alzheimer’s 3 Disease
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Alzheimer’s disease (AD) remains a significant challenge in the field of neurodegenerative 10 disorders, even...
mRNA and Synthesis-Based Therapeutic Proteins: A Non-Recombinant Affordable Option
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Abstract: Recombinant technology has been around for nearly three quarters of a century and has revolutionized...
Advances in Escherichia coli-Based Therapeutic Protein Expression: Mammalian Conversion, Continuous Manufacturing, and Cell-Free Production
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Abstract: Therapeutic proteins treat many acute and chronic diseases that were until recently consid- ered untreatable....
Microbiome Impact on Neurological and Autoimmune Disor- 2 ders: A Novel Healthcare Resolution
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Simple Summary: It is vitally important that scientists are able to describe their work simply and...